CEACAM5 and colorectal carcinoma: In this study, we systematically evaluate MIC-1 as a candidate complementary biomarker for screening early-stage CRC by comparison with CEA, and furthermore, for the first time, identifying a promising prognostic indicator for monitoring recurrence with liver metastasis, to support strategies towards personalized therapy.